HomeAbout

TL;DR CNBC


Weight loss drugs cut Covid-19 deaths, study finds - TL;DR CNBC

Weight loss drugs cut Covid-19 deaths, study finds

Publishing timestamp: 2024-09-02 07:55:23


Summary

A new study published in the Journal of American College of Cardiology found that people taking the key component of weight loss drugs Ozempic and Wegovy were less likely to die of Covid-19 or suffer adverse effects from the virus. The drug, semaglutide, also showed a reduction in deaths from causes not linked to heart events and improved symptoms linked to heart failure and inflammation. This discovery could open up the drug for further uses and boost Novo Nordisk's value. Further research is needed to fully understand the impacts of semaglutide.


Sentiment: POSITIVE

Tickers: NOVO.B-DKLLY

Keywords: pharmaceuticalsbusiness newsnovo nordisk a/smarketsbusinesseli lilly and cobreaking news: markets

Source: https://www.cnbc.com/2024/09/02/weight-loss-drugs-cut-covid-deaths.html


Developed by Leo Phan